By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Caliper Life Sciences today reported an 8 percent decrease in year-over-year revenues for its third quarter due to divestitures in 2009-2010, but on an organic basis revenues were up 11 percent.

The Hopkinton, Mass.-based firm had total revenues of $29.7 million for the three-month period ended Sept. 30, compared to $32.2 million for the third quarter of 2009. It beat analysts' consensus estimate for revenues of $27.5 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

New Mexico is re-doing its proposed science education standards after criticism, the Associated Press reports.

Agbio executives say gene editing will speed up breeding efforts, according to the Wall Street Journal.

La Trobe University's Jenny Graves has won the $250,000 Prime Minister's Prize for Science, the Guardian reports.

In Cell this week: post-treatment changes to melanoma genome, multi-omics analysis of muscle-invasive bladder cancer, and more.